Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,570.00
Bid: 1,550.00
Ask: 1,590.00
Change: -10.00 (-0.63%)
Spread: 40.00 (2.581%)
Open: 1,545.00
High: 1,570.00
Low: 1,545.00
Prev. Close: 1,580.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update

20 Apr 2020 07:00

RNS Number : 0942K
Cerillion PLC
20 April 2020
 

20 April 2020

AIM: CER

 Cerillion plc

("Cerillion" or "the Company")

 

Half Year Trading Update

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2020, and comments on the impact of the coronavirus pandemic on the business.

 

The Company's primary focus is the safety and welfare of its staff and customers. Management is monitoring government guidance regarding the coronavirus pandemic and has taken action to ensure that all staff are able to operate safely while continuing to provide the full range of the Company's services to customers.

 

Trading Update

 

Cerillion has traded strongly in the six months to 31 March 2020, in line with management expectations. This reflects the four major new contracts signed from mid-June onwards in 2019 as well as continuing demand from existing customers. Prospects for the remainder of the financial year continue to look very positive.

 

Revenue for the first half is expected to total approximately £10.2m, an increase of 46% on the comparative period last year (H1 2019: £7.0m), although the timing of the closure of major contracts in 2019 resulted in that year being more second-half weighted than normal. Adjusted EBITDA is expected to be £2.7m (H1 2019: £0.4m), a record first half since the Company was admitted to AIM in 2016.

 

The Company's balance sheet remains strong, with net cash at 31 March 2020 of £4.8m (31 March 2019: £2.6m).

Reflecting the momentum in the business, the Company has added further resource, and its sales pipeline remains encouraging. In April, the Company agreed a major upgrade and a five year contract extension with Manx Telecom, a long-established customer, in which Manx Telecom moved to a new SaaS agreement.

 

In the period, the Company also released Cerillion 8.1, the latest version of its enterprise OSS/BSS suite for fixed, mobile, cable and multi-service operators. The new software provides customers with significant operational efficiencies, drives customer engagement through mobile devices, and opens new channels for customer growth including through Mobile App, which enables in-app purchases.

 

Coronavirus Pandemic

 

While additional precautions are being taken regarding staff safety, the Company has not experienced any slowdown in trading activity to date. Cerillion's customers are predominantly telecommunications operators providing critical infrastructure and services, and operators are currently typically seeing strong data traffic levels arising from national 'lockdowns' across the globe. The Board therefore believes that there is a substantial degree of resilience to Cerillion's business model.

 

Notice of results

 

The Board intends to announce interim results for the six months to 31 March 2020 in mid-May 2020, when the Company will provide a further update on current trading. 

 

Louis Hall, Chief Executive of Cerillion, commented:

 

"Trading continues to show strong momentum, reflecting last year's record level of major new orders, and we have recruited more staff to support ongoing growth. We remain confident about prospects for the remainder of the year, given the existing strong order book, and the pipeline of potential new business remains encouraging.

 

"Cerillion's long-term prospects remain very positive, underpinned by the quality and growing relevance of our product offering, which is gaining increasing market recognition, as well as the growth opportunities we see in our market."

 

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Oliver Gilchrist, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Euan Brown, William Hall

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

 

 

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 90 customer installations across over 40 countries.

 

Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMZGMDKNLGGZM
Date   Source Headline
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights
21st May 202112:26 pmRNSDirector/PDMR Shareholding
17th May 20214:33 pmRNSHolding(s) in Company
17th May 20217:00 amRNSInterim Results
19th Apr 20217:00 amRNSHalf Year Trading Update
29th Mar 20217:00 amRNSLargest Ever Contract Win
17th Mar 20215:47 pmRNSShare Purchase for Long-Term Incentive Plan
12th Mar 20215:43 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSMajor Channel Partner Yields First Contract
11th Feb 20215:14 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSPDMR Share Transfer
5th Feb 20219:31 amRNSResult of AGM
4th Feb 20213:00 pmRNSHolding(s) in Company
4th Feb 202112:09 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:13 pmRNSDirector/PDMR shareholding
30th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20206:07 pmRNSHolding(s) in Company
18th Dec 20201:17 pmRNSHolding(s) in Company
26th Nov 20208:53 amRNSHolding(s) in Company
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:37 pmRNSHolding(s) in Company
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.